Clinical Trials

Status
Title Intervention Sponsor Status
The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) Placebo, Sulindac 400 MG Duke University Recruiting
ASPirin Intervention for the REDuction of Colorectal Cancer Risk Placebo for Aspirin, Aspirin Massachusetts General Hospital Active, not recruiting
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine, Quality-of-Life Assessment, Saline National Cancer Institute (NCI) Active, not recruiting
CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts Ethanol, Normal saline, Paclitaxel + Gemcitabine admixture Milton S. Hershey Medical Center Active, not recruiting
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid National Cancer Institute (NCI) Active, not recruiting
Chemoprevention of Gastric Carcinogenesis Eflornithine, Eflornithine placebo Vanderbilt-Ingram Cancer Center Active, not recruiting
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia Curcumin, Laboratory Biomarker Analysis, Placebo Administration, Quality-of-Life Assessment National Cancer Institute (NCI) Active, not recruiting
Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study Biospecimen Collection, Lisinopril, Liver Ultrasonographic Elastography, Magnetic Resonance Elastography, Magnetic Resonance Imaging, Proton Density Fat Fraction, Questionnaire Administration National Cancer Institute (NCI) Recruiting
Obeticholic Acid for Prevention in Barrett's Esophagus Biospecimen Collection, Esophageal Biopsy, Esophagogastroduodenoscopy, Liver Ultrasonographic Elastography, Obeticholic Acid, Placebo Administration, Questionnaire Administration National Cancer Institute (NCI) Recruiting
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Placebo Administration, Questionnaire Administration, Simvastatin National Cancer Institute (NCI) Active, not recruiting